Mixed allogeneic chimerism and tolerance to composite tissue allografts

Microsurgery

Volumn 20, Issue 8, 2000, Pages 441-447

  Prabhune, Kaustubha A ^a   Gorantla, Vijay S ^a   Maldonado, Claudio ^a   Perez Abadia, Gustavo ^a   Barker, John H ^a   Ildstad, Suzanne T ^a,b  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOGRAFT; ALLOTRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGENICITY; BONE MARROW TRANSPLANTATION; CHIMERA; COMPOSITE GRAFT; CONFERENCE PAPER; CONTROLLED STUDY; GRAFT REJECTION; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; MOUSE; MULTIPLE ORGAN FAILURE; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS;

ANIMALS; BONE MARROW TRANSPLANTATION; GRAFT REJECTION; GRAFT VS HOST DISEASE; HUMANS; IMMUNE TOLERANCE; IMMUNOSUPPRESSIVE AGENTS; TISSUE TRANSPLANTATION; TRANSPLANTATION CHIMERA; TRANSPLANTATION, HOMOLOGOUS;

EID: 0034509974     PISSN: 07381085     EISSN: None     Source Type: Journal    
DOI: 10.1002/1098-2752(2000)20:8<441::AID-MICR16>3.0.CO;2-A     Document Type: Conference Paper

References (58)

1. A history of transplantation: Thirty-five recollections. Los Why do immunosuppressed patients develop cancer?
2. Problems related to immunosuppression. Infection and malignancy occurring after solid organ transplantation
3. Immunogenetic consequences of vascular anastomoses between bovine twins
4. The use of skin grafting to distinguish between homozygotic and dizygotic twins in cattle
5. Cell migration, chimerism and graft acceptance
6. Chimerism after organ transplantation: Is there any clinical significance?
7. Patterns of donor type microchimerism after heart transplantation
8. Status of microchimerism in recipients 15 years after living related kidney transplantation
9. Mixed allogeneic chimeras (A + B → A): Evidence for syngeneic and allogeneic donor stem cell coengraftment and stable multilineage chimerism
10. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B 10 + B10.D2 →B10)
11. MHC-restricted cytotoxic T-cells: Studies on the biological role of polymorphic major transplantation antigens determining T cell restriction specificity, function, and responsiveness
12. On the immunoincompetence of H-2 incompatible irradiated bone marrow chimeras
13. Antiviral T cell competence and restriction specificity of mixed allogeneic (P1 + P2 → P1) irradiation chimeras
14. Characterization of mixed allogeneic chimeras. Immunocompetence, in vitro reactivity, and genetic specificity of tolerance
15. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts
16. Stable mixed chimerism and tolerance using a nonmyeloablative preparative regimen in a large-animal model
17. Mixed chimerism and tolerance without whole body irradiation in a large animal model
18. Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys
19. Aplastic anemia treated with daily transfusions and intravenous marrow: Case report
20. Modification of irradiation injury in mice and guinea pigs by bone marrow injection
21. Durable mixed allogeneic chimerism and tolerance by a nonlethal radiation-based cytoreductive approach
22. Tolerance of allogeneic heart grafts in mice simultaneously reconstituted with purified allogeneic hematopoietic stem cells
23. Mixed hematopoietic chimerism induces donor-specific tolerance for lung allografts in rodents
24. Mixed xenogeneic chimerism (mouse + rat → mouse) to induce donor-specific tolerance to sequential or simultaneous islet xenografts
25. Tolerance to donor-type skin in the recipient of a bone marrow allograft. Treatment of skin ulcers in chronic graft-versus-host disease with skin grafts from the bone marrow donor
26. Immunologic tolerance to renal allografts after bone marrow transplants from the same donors
27. Severe graft-versus-host disease in a liver-transplant recipient
28. Lethal graft-versus-host disease after simultaneous kidney-pancreas transplantation
29. Graft-versus-host disease in fully allogeneic small bowel transplantation in the rat
30. Human marrow transplantation: An immunological perspective
31. Bone marrow transplantation
32. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program
33. Marrow transplants from unrelated donors for treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia
34. T cell depletion for graft-versus-host disease prophylaxis. A perspective on engraftment in mice and humans
35. Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow
36. Transplantation for acute leukemia with HLA-A and B nonidentical parental marrow cells fractionated with soyabean agglutinin and sheep red blood cells
37. A correlation between conditioning and engraftment on recipients of MHC-mismatched T cell depleted murine bone marrow transplants
38. Phenotypic characterization of a novel bone marrow-derived cell that facilitates engraftment of allogeneic bone marrow stem cells
39. Lymphohemopoietic reconstitution using wheat germ agglutinin-positive hemopoietic stem cell transplantation within but not across the major histocompatibility antigen barriers
40. Potential and distribution of transplanted hematopoietic stem cells in a nonablated mouse model
41. Use of homozygous allogeneic bone marrow for induction of tolerance with antilymphocyte serum-dose and timing
42. Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance
43. Mixed allogeneic chimeras prepared by a non-myeloablative regimen: Requirement for chimerism to maintain tolerance
44. In vivo depletion of host CD4+ and CD8+ cells permits engraftment of bone marrow stem cells and tolerance induction with minimal conditioning
45. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers
46. Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation
47. Tissue engineering
48. Relative antigenicity of components of a vascularized limb allograft
49. Donor-specific tolerance induction in composite tissue allografts
50. Kinetics of bone marrow repopulation in lethally irradiated rats after transplantation of vascularized bone marrow in syngeneic hind limb
51. Reconstitution of lymphoid tissue after vascularized bone marrow transplantation
52. Microchimerism following allogeneic vascularized bone marrow transplantation - Its possible role in induction of posttransplantation tolerance
53. Development of stable mixed T cell chimerism and transplantation tolerance without immune modulation in recipients of vascularized bone marrow allografts
54. Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment
55. Cutting edge: Administration of anti-CD40 ligand and donor bone marrow leads to hemopoietic chimerism and donor-specific tolerance without cytoreductive conditioning
56. Establishment of stable multilineage hematopoietic chimerism and donor-specific tolerance without irradiation
57. The role of T-cell costimulatory activation pathways in transplant rejection